Host-pathogen interactions: Redefining the basic concepts of virulence and pathogenicity

Infection and Immunity

Volumn 67, Issue 8, 1999, Pages 3703-3713

  Casadevall, Arturo ^a   Pirofski, Liise Anne ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOST SUSCEPTIBILITY; IMMUNE RESPONSE; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; SHORT SURVEY; STREPTOCOCCUS PNEUMONIAE; VIRULENCE;

EID: 0032765322     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.8.3703-3713.1999     Document Type: Short Survey

References (35)

1. Allen, J. E., and R. M. Maizels. 1997. Th1-Th2: reliable paradigm or dangerous dogma. Immunol. Today 18:387-392.
2. Armstrong, D. 1993. History of opportunistic infection in the immunocompromised host. Clin. Infect. Dis. 17(Suppl. 2):S318-S321.
3. Brubaker, R. R. 1985. Mechanisms of bacterial virulence. Annu. Rev. Microbiol. 39:21-50.
4. Deitsch, K. W., E. R. Moxon, and T. E. Wellems. 1997. Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. Microbiol. Mol. Biol. Rev. 61:281-293.
5. Dubos, R. J. 1945. The bacterial cell, p. 188-228. Harvard University Press, London, United Kingdom.
6. Evans, A. S. 1976. Causation and disease: the Henle-Koch postulates revisited. Yale J. Biol. Sci. 49:175-195.
7. Ewald, P. W. 1993. The evolution of virulence. Sci. Am. 268:86-93.
8. Falk, I. S. 1928. A theory of microbiologic virulence, p. 565-575. In E. O. Jordan and I. S. Falk. (ed.), The newer knowledge of bacteriology and immunology. The University of Chicago Press, Chicago, Ill.
9. Falkow, S. 1988. Molecular Koch's postulates applied to microbial pathogenicity. Rev. Infect. Dis. 10(Supp 2):S274-S276.
10. Falkow, S. 1997. What is a pathogen? ASM News 63:359-365.
11. Finlay, B. B., and S. Falkow. 1997. Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 61:136-169.
12. Ford, W. W. 1927. Text-book of bacteriology, p. 826-844. W. B. Saunders Company, Philadelphia, Pa.
13. Hacker, J., G. Blum-Oehler, I. Mühldorfer, and H. Tschäpe. 1997. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol. Microbiol. 23:1089-1097.
14. Harries, E. H. R., M. Mitman, and I. Taylor. 1951. Clinical practice in infectious diseases, p. 15-16. The Williams and Wilkins Co., Baltimore, Md.
15. Heinzel, F. P. 1995. Th1 and Th2 cells in the cure and pathogenesis of infectious diseases. Curr. Opin. Immunol. 8:151-155.
16. Henderson, B., S. Poole, and M. Wilson. 1996. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev. 60:316-341.
17. Hoeprich, P. D. 1983. Host-parasite relationships and the pathogenesis of infectious disease, p. 45-56. In P. D. Hoeprich. (ed.), Infectious diseases. Harper & Row, Philadelphia, Pa.
18. Ingham, H. R., and P. R. Sisson. 1984. Pathogenic synergism. Microbiol. Sci. 1:206-208.
19. Isenberg, H. D. 1988. Pathogenicity and virulence: another view. Clin. Microbiol. Rev. 1:40-53.
20. Janeway, C. A., C. C. Goodnow, and R. Medzhitov. 1996. Immunological tolerance: danger - pathogen on the premises! Curr. Biol. 6:519-522.
21. Lipsitch, M., and E. R. Moxon. 1997. Virulence and transmissibility of pathogens: what is the relationship? Trends Microbiol. 5:31-37.
22. Mackowiak, P. A. 1987. Microbial oncogenesis. Am. J. Med. 82:79-97.
23. Pirofski, L., and A. Casadevall. 1998. The use of licensed vaccines for active immunization of the immunocompromised host. Clin. Microbiol. Rev. 11:1-26.
24. Read, A. F. 1994. The evolution of virulence. Trends Microbiol. 2:73-81.
25. Romagnani, S. 1996. Understanding the role of the Th1/Th2 cells in infection. Trends Microbiol. 4:470-473.
26. Rosenow, E. C. 1907. Human pneumococcal opsonin and the anti-opsonic substance in virulent pneumococci. J. Infect. Dis. 4:285-296.
27. Smith, H. 1977. Microbial surfaces in relation to pathogenicity. Bacteriol. Rev. 41:475-500.
28. Smith, T. 1913. An attempt to interpret present-day uses of vaccines. JAMA 60:1591-1599.
29. Smith, T. 1934. Parasitism and disease, p. 112-129. Hafner Publishing Co., New York, N.Y.
30. Sokurenko, E. V., V. Chesnokova, D. Dykhuizen, I. Ofek, X. Wu, K. A. Krogfelt, C. Struve, M. A. Schembri, and D. L. Hasty. 1998. Pathogenic adaptation of Escherichia coli by natural variation of the FimH adhesin. Proc. Natl. Acad. Sci. USA 95:8922-8926.
31. Sparling, P. F. 1983. Bacterial virulence and pathogenesis: an overview. Rev. Infect. Dis. 5(Suppl. 4):S637-S646.
32. Watson, D. W., and C. A. Brandly. 1949. Virulence and pathogenicity, p. 195-220. In C. E. Clifton, S. Raffel, and H. A. Barker. (ed.), Annual review of microbiology. Annual Reviews, Inc., Stanford, Calif.
33. Wood, W. B., and B. D. Davis. 1980. Host-parasite relations in bacterial infections, p. 551-571. In B. D. Davis, R. Dulbecco, H. N. Eisen, and H. S. Ginsberg. (ed.), Microbiology. Harper & Row, Cambridge, Mass.
34. Youmans, G. P., P. Y. Paterson, and H. M. Sommers. 1975. The biologic and clinical basis of infectious diseases, p. 12-13. W. B. Saunders Co., Philadelphia, Pa.
35. Zinsser, H. 1914. Infection and resistance, p. 1-27. The Macmillan Company, New York, N.Y.